[Use of pneumococcal vaccine in patients with renal pathology].
The use of pneumococcal polysaccharide vaccine in patients with chronic renal pathology has proved to be expedient as it prevents the development of pneumococcal infection. However, active immunosuppressive therapy and massive proteinuria result in decreased duration of antibody persistence, which makes in necessary to repeat the injection of the vaccine 20-22 months after the first vaccination.
Shavyrin
A A
AA
Mechnikov Research Institute for Vaccines and Sera, Moscow, Russia.
Kostinov
M P
MP
Magarshak
O O
OO
Ryzhov
A A
AA
Seu
L N
LN
D000328:Adult; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D006801:Humans; D007075:Immunoglobulin M / Q000097:blood / Q000276:immunology; D007674:Kidney Diseases / Q000097:blood / Q000150:complications / Q000276:immunology*; D011008:Pneumococcal Infections / Q000276:immunology / Q000517:prevention & control*; D022242:Pneumococcal Vaccines; D014611:Vaccination
D007075:Immunoglobulin M; D022242:Pneumococcal Vaccines